Praxis Precision Medicines Reviews Unfavorable Outcomes from PRAX-114 Section 2/3 Monotherapy Aria Examine in Sufferers with Main Depressive Dysfunction
Praxis Precision Medicines, Inc. Aria Examine didn’t obtain statistical significance on the first endpoint Strategic